Literature DB >> 30150672

Author Correction: Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion.

Zhenrui Li1,2, Pengxu Qian3,4,5, Wanqing Shao1, Hailing Shi6,7, Xi C He1, Madelaine Gogol1, Zulin Yu1, Yongfu Wang1, Meijie Qi8, Yunfei Zhu8, John M Perry1, Kai Zhang1, Fang Tao1, Kun Zhou1,9, Deqing Hu1,10, Yingli Han1, Chongbei Zhao1, Richard Alexander1, Hanzhang Xu11, Shiyuan Chen1, Allison Peak1, Kathyrn Hall1, Michael Peterson1, Anoja Perera1, Jeffrey S Haug1, Tari Parmely1, Hua Li1, Bin Shen8, Julia Zeitlinger1, Chuan He6,7, Linheng Li12,13.   

Abstract

In the initial published version of this article, there was an inadvertent omission from the Acknowledgements that this work was supported by Stowers Institute for Medical Research (SIMR-1004) and NIH National Cancer Institute grant to University of Kansas Cancer Center (P30 CA168524). This omission does not affect the description of the results or the conclusions of this work.

Entities:  

Year:  2018        PMID: 30150672      PMCID: PMC6170484          DOI: 10.1038/s41422-018-0083-x

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  2 in total

Review 1.  RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.

Authors:  Lan Yao; Hua Yin; Mei Hong; Yajun Wang; Tingting Yu; Yao Teng; Tingting Li; Qiuling Wu
Journal:  Leukemia       Date:  2021-03-25       Impact factor: 12.883

2.  Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.

Authors:  Nanfang Qu; Sanyu Qin; Xuemei Zhang; Xiaotong Bo; Zhengchun Liu; Chao Tan; Guiqiong Wen; Haixing Jiang
Journal:  BMC Cancer       Date:  2020-02-28       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.